Clinical Trials

Overview

About this study

The purpose of this study is to collect samples for hscTnT and hscTnI at baseline in those being started on ICIs who are identified by the clinicians treating these patients and then again subsequently when/if they develop myocarditis and are identified by the CardioOncology service.  The baseline samples will allow for analysis as to whether having an increased hscTn value at baseline is associated with a higher risk of myocarditis.  hscTnT is clinically necessary but hscTnI may not be. Then a proper assessment of the sensitivity, specificity, positive and negative predictive values of this testing will be accomplished.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Participating Mayo Clinic locations

More information